AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma
@article{Mediastinum9610,
author = {Ning Xu and Wentao Fang},
title = {AB050. SHR-1316 plus nab-paclitaxel and carboplatin as the first line therapy for advanced, unresectable, recurrent or metastatic thymic carcinoma},
journal = {Mediastinum},
volume = {8},
number = {0},
year = {2024},
keywords = {},
abstract = {},
issn = {2522-6711}, url = {https://med.amegroups.org/article/view/9610}
}